About Us
Mission & Values
SteriTek is committed to providing the highest quality E-beam irradiation services and complete customer support that offers exceptional responsiveness in serving your needs.
Our goal is to create a partnership with you by providing rapid processing and superior business, technical, operational and regulatory support. Our philosophy is very simple: provide the highest standards in the industry – from R&D and testing to validation and production and beyond. All of SteriTek’s E-beam sterilization services meet or exceed, ISO 13485 and 11137 & standards and SAL requirements. We take our QA and QC processes seriously.
So whether you need high-volume, on-demand, or customer services for R&D, testing, validation or production, we make sure your high standards are met every step of the way.
We stand ready to be of service to you and your company!
~ The SteriTek team
Meet our team
Larry Nichols
Chief Executive Officer
Chris Brandon
COO & CFO
Jeff Sauter
Director Business Development
Jordan Fujioka
Director of Operations
Jeff Sauter
Director Business Development
Jeff collaborates with medtech and biotech innovators in helping SteriTek’s customers on their way towards successful commercialization by achieving optimal E-beam/X-ray sterilization and processing throughput of their medical device or drug/biologic product.
Jeff has 15 plus years of experience in consulting multinational and Fortune 500 companies and holds a B.A. degree in Economics from the University of Illinois-Chicago.
Jordan Fujioka
Director of Operations
Jordan has spent the last 9 years learning the ins and outs of the contract sterilization industry working with Technical, Regulatory, Quality System and Operation teams for electron beam sterilization. He currently oversees the day to day at Steri-Tek Fremont and ensures that all customers are provided the best Customer Service to ensure commercial success.
Jordan has over 10 years of experience in the MedTech Industry and holds a B.S. degree in Biology from the University of California Riverside.
Larry Nichols
Chief Executive Officer
Larry began working in the E-beam industry for Nutek Corp in 1996 as the business manager. He soon assumed the position of Operations Manager, overseeing the shipping/receiving department as well as the machine operators. While at Nutek, he held the positions of Quality Manager, VP of Operations, and VP of Business Development. In 2009, he assumed the position of CEO. In 2010, he became active on the committees ISO/AAMI 11137 and ASTM Dosimetry working group. When Nutek closed in 2016, he co-founded Steri-Tek, where he assumed the role of CEO.
Larry earned his BS degree in Business Management from Cal Poly in San Luis Obispo, CA.
Chris Brandon
COO & CFO
Chris Brandon possesses over 30 years of operational and financial management leadership experience. He has raised capital for high and low-technology ventures, set up distribution operations, managed international-based subsidiaries, and directed numerous successful M&A transactions. Chris has worked for technology companies serving in roles including CEO, COO, CFO, VP Ops, and Director of Strategic Planning, as well as an independent consultant and strategic advisor.
Education: MBA in finance with honors from Emory University, Atlanta, and a BA in Business (Magna Cum Laude) from the University of Washington in Seattle.
Partners
SteriTek continuously seeks to build partnerships with world class companies providing Testing Services, R&D and Regulatory support. Please visit one of our partners and let’s discuss how we can collaborate!
Our Facilities
SteriTek’s flagship facility in Silicon Valley (Fremont, CA) boasts two state-of-the-art 10 MeV 20 kW linear accelerators, using simultaneous beam processing that allows for high volume production, providing uniform dose to the product without having to rotate the customer’s boxes. This DualBeam™ configuration significantly increases efficiencies, expands product options, and serves as an effective backup for the accelerators.
Our newest facility in Dallas (Lewisville, TX) with operations starting in late 2022 will house three separate lines, two E-beam/X-ray 10 MeV, 30 kW DualBeam™ lines, and a dedicated X-ray 7 MeV, 560 kW line which together will increase the total throughput by fivefold, once in full operation.